GNH USA

Europe — EMA

Paramol (Dihydrocodeine Tartrate, Paracetamol)

Dihydrocodeine tartrate, the active ingredient in Paramol, is an opioid analgesic presented as a combination tablet for oral use. It is used to treat moderate to severe pain in adults when other analgesics are…

Request sourcing

1
Pack/s

What is Dihydrocodeine Tartrate, Paracetamol?

Dihydrocodeine tartrate, the active ingredient in Paramol, is an opioid analgesic presented as a combination tablet for oral use. It is used to treat moderate to severe pain in adults when other analgesics are insufficient.

GNH USA supplies Paramol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Dihydrocodeine Tartrate, Paracetamol used for?

Paramol combines dihydrocodeine tartrate and paracetamol, acting on both central pain pathways and peripheral prostaglandin synthesis to relieve moderate to severe pain. - Acute postoperative pain: provides short‑term relief during the recovery period after surgery. - Cancer‑related pain: offers continuous control of persistent pain through opio‑ and non‑opio mechanisms. - Severe musculoskeletal pain: helps manage pain from musculoskeletal injuries or conditions . - Chronic dys‑     

What are the side effects of Dihydrocodeine Tartrate, Paracetamol?

Common S  

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Dihydrocodeine Tartrate, Paracetamol
Route
Oral Use
Manufacturer
Reckitt Benckiser Healthcare (Uk) Ltd
Origin
EU

Related products